Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. Operating Income 2024–2025
Evommune, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Evommune, Inc. operating income for the quarter ending March 31, 2026 was -24.0 M, a 59.35% increase year-over-year.
- Evommune, Inc. annual operating income for 2025 was -81.1 M, a 15.79% increase from 2024.
- Evommune, Inc. annual operating income for 2024 was -70.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Evommune, Inc. Operating Income — FAQ
Evommune, Inc. (EVMN) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Evommune, Inc.'s operating income?
Evommune, Inc. (EVMN) reported operating income of -$81M for fiscal 2025.
Where can I see EVMN's operating income history?
The chart and table above show Evommune, Inc.'s operating income by year and by quarter, including the growth rate.